For the Inventor, By the Inventor

Enter inventor name

Mir A Imran

Palo Alto, CA, United States of America

Mir A Imran

USPTO Granted Patents = 449 (Patent Applications = 102)

Average Co-Inventor Count = 1.4

ph-index = 98

Forward Citations = 41,560(Granted Patents)

Forward Citations (Not Self Cited) = 36,746(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Pittsburgh, PA (US) (1983 - 1986)
Gibsonia, PA (US) (1987)
San Francisco, CA (US) (1988 - 1989)
Palo Alto, CA (US) (1988 - 1999)
Los Atlos Hills, CA (US) (2013)
Menlo Park, CA (US) (2006 - 2017)
San Jose, CA (US) (2023)
Los Altos Hills, CA (US) (1997 - 2024)
Los Altos, CA (US) (2012 - 2024)

Company Filing History:

Incube Labs, LLC

Rani Therapeutics, LLC

Cardiac Pathways Corporation

4. 32 out of 34

Intrapace, Inc.

5. 17 out of 24

Spinal Modulation, Inc.

6. 16 out of 16

Intelliwire, Inc.

7. 13 out of 5,309

Leland Stanford Junior University

8. 11 out of 11

9. 11 out of 11

Python Medical, Inc.

10. 9 out of 16

Physiometrix, Inc.

11. 8 out of 12

St. Jude Medical Luxembourg Holdings Smi S.a.r.l. (“sjm Lux Smi”)

Surface Genesis, Inc.

13. 6 out of 12

Intella Interventional Systems, Inc.

Advanced Cytometrix, Inc.

Cardiovasc, Inc.

17. 2 out of 18

Percusurge, Inc.

19. 2 out of 28

Zonare Medical Systems, Inc.

Fe3 Medical, Inc.

St. Jude Medical Luxembourg Holdings Smi S.a.r.l.

Mircor Biomedical, Inc.

23. 1 out of 110

Medtronic Ave, Inc.

Spinal Modulations, Inc.

25. 1 out of 16

Fox Hollow Technologies, Inc.

Novasonics, Inc.

27. 1 out of 974

Medtronic Vascular, Inc.

29. 1 out of 62

Mieczyslaw Mirowski

31. 1 out of 14

Medtronic Percusurge, Inc.

Advanced Cytometric Inc.

33. 1 out of 30

Supra Products, Inc.

Mirowski; Mieczyslaw

Phyronics, Inc.

Incube Laboratories LLC

37. 1 out of 286

38. 18 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...

Areas of Expertise:

Swallowable Drug Delivery

Therapeutic Compounds

Microtablet Manufacturing

Neurogenic Bladder Treatment

Biodegradable Drug Delivery

Insulin Delivery Systems

Gastrointestinal Therapeutics

Urethral Catheters

Stem Cell Therapy

Medical Implants

Bladder Control Systems

Incretin Stimulation

449 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268831 - Swallowable drug delivery device and methods of drug delivery (2025-04-08),

2. 12263325 - Device, system and methods for the oral delivery of therapeutic compounds (2025-04-01),

3. 12214019 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2025-02-04),

4. 12201845 - Anchor system for retaining a device in tissue (2025-01-21),

5. 12201721 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2025-01-21),

6. 12171724 - Method and apparatus for manufacturing microtablets (2024-12-24),

7. 12133980 - Device, systems and methods for treatment of neurogenic bladder (2024-11-05),

8. 12128133 - Ingestible device with expandable enclosure (2024-10-29),

9. 12115195 - Method for treating diabetes and other glucose regulation disorders using stem cells (2024-10-15),

10. 12018090 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2024-06-25),

11. 11944780 - Multi-stage biodegradable drug delivery platform (2024-04-02),

12. 11890472 - Selective stimulation systems and signal parameters for medical conditions (2024-02-06),

13. 11872396 - Swallowable capsule and method for stimulating incretin production within the intestinal tract (2024-01-16),

14. 11844867 - Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device (2023-12-19),

15. 11833319 - Propulsive drug delivery from a swallowable device into a patients intestinal tract (2023-12-05),

Title: Mir A Imran: Innovator in Swallowable Drug Delivery Technologies

Introduction

Mir A Imran is a prolific inventor based in Palo Alto, California, with an impressive portfolio of 428 patents. His groundbreaking work primarily focuses on innovations in drug delivery systems, aiming to enhance the effectiveness of therapeutic agents within the gastrointestinal (GI) tract.

Latest Patents

Among his latest innovations are patents for a swallowable drug delivery device and methods of drug delivery. These inventions represent advancements in medical technology, providing solutions for delivering drugs and therapeutic agents effectively within the GI tract. One of the key embodiments is a swallowable capsule designed to deliver medications into the intestinal wall or other areas of the GI lumen. This capsule incorporates a guide tube, tissue penetrating members, a delivery member, an actuating mechanism, and a release element that degrades under specific conditions in the intestine, allowing for the targeted delivery of drugs that are typically poorly absorbed or tolerated in the GI tract.

Another remarkable patent involves a device and system for the oral delivery of therapeutic compounds. This invention outlines a swallowable device, like a capsule, which contains drug preparations that are advanced into the intestinal wall and degrade to release effective doses to produce therapeutic effects. This system is particularly beneficial for drugs that are challenging to administer effectively within the digestive system.

Career Highlights

Throughout his career, Mir A Imran has made significant contributions to the field of medical technology. He has held positions in influential companies such as Incube Labs, LLC and Rani Therapeutics, LLC. His work continues to push the boundaries of how medications are delivered and absorbed in the body, showcasing his talent as an inventor.

Collaborations

Collaboration has played a vital role in Mir A Imran's journey. He has worked alongside talented individuals, including Mir Hashim and Radhika Korupolu, contributing to the development of revolutionary drug delivery systems.

Conclusion

Mir A Imran's innovative patents and contributions to drug delivery technology underscore his status as a leading inventor in the medical field. His commitment to improving the efficiency of therapeutic delivery methods continues to pave the way for advancements that could significantly enhance patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…